Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ikezoe

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
American Journal of Hematology|March 11, 1999
Analysis of the Smad5 gene in hematological malignanciesT Ikezoe, S Takeuchi, M Kobayashi, et al.
Leukemia|August 7, 2009
Sunitinib, an orally available receptor tyrosine kinase inhibitor, induces monocytic differentiation of acute myelogenous leukemia cells that is enhanced by 1,25-dihydroxyvitamin D(3)C Nishioka, T Ikezoe, J Yang, et al.
Leukemia|August 14, 2009
Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2/STAT5 signaling in acute myelogenous leukemia cellsC Nishioka, T Ikezoe, J Yang, et al.
Bone Marrow Transplantation|November 13, 2007
Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kappaBC Nishioka, T Ikezoe, K Togitani, et al.
Bone Marrow Transplantation|September 23, 2014
Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleenT Ikezoe, J Yang, C Nishioka, et al.
Leukemia|July 3, 2010
Long-term exposure of leukemia cells to multi-targeted tyrosine kinase inhibitor induces activations of AKT, ERK and STAT5 signaling via epigenetic silencing of the PTEN geneC Nishioka, T Ikezoe, J Yang, et al.
British Journal of Cancer|May 13, 2004
JNK interacting protein 1 (JIP-1) protects LNCaP prostate cancer cells from growth arrest and apoptosis mediated by 12-0-tetradecanoylphorbol-13-acetate (TPA)T Ikezoe, Y Yang, H Taguchi, et al.
International Journal of Hematology|January 14, 1999
Analysis of the Smad3 gene in hematological malignanciesT Ikezoe, S Takeuchi, T Arai, et al.
Bone Marrow Transplantation|July 7, 2010
Recombinant human soluble thrombomodulin counteracts capillary leakage associated with engraftment syndromeT Ikezoe, A Takeuchi, A Taniguchi, et al.
Bone Marrow Transplantation|September 22, 2009
Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulinM Sakai, T Ikezoe, K Bandobashi, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
American Journal of Hematology|March 11, 1999
Analysis of the Smad5 gene in hematological malignanciesT Ikezoe, S Takeuchi, M Kobayashi, et al.
Leukemia|August 7, 2009
Sunitinib, an orally available receptor tyrosine kinase inhibitor, induces monocytic differentiation of acute myelogenous leukemia cells that is enhanced by 1,25-dihydroxyvitamin D(3)C Nishioka, T Ikezoe, J Yang, et al.
Leukemia|August 14, 2009
Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2/STAT5 signaling in acute myelogenous leukemia cellsC Nishioka, T Ikezoe, J Yang, et al.
Bone Marrow Transplantation|November 13, 2007
Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kappaBC Nishioka, T Ikezoe, K Togitani, et al.
Bone Marrow Transplantation|September 23, 2014
Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleenT Ikezoe, J Yang, C Nishioka, et al.
Leukemia|July 3, 2010
Long-term exposure of leukemia cells to multi-targeted tyrosine kinase inhibitor induces activations of AKT, ERK and STAT5 signaling via epigenetic silencing of the PTEN geneC Nishioka, T Ikezoe, J Yang, et al.
British Journal of Cancer|May 13, 2004
JNK interacting protein 1 (JIP-1) protects LNCaP prostate cancer cells from growth arrest and apoptosis mediated by 12-0-tetradecanoylphorbol-13-acetate (TPA)T Ikezoe, Y Yang, H Taguchi, et al.
International Journal of Hematology|January 14, 1999
Analysis of the Smad3 gene in hematological malignanciesT Ikezoe, S Takeuchi, T Arai, et al.
Bone Marrow Transplantation|July 7, 2010
Recombinant human soluble thrombomodulin counteracts capillary leakage associated with engraftment syndromeT Ikezoe, A Takeuchi, A Taniguchi, et al.
Bone Marrow Transplantation|September 22, 2009
Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulinM Sakai, T Ikezoe, K Bandobashi, et al.
Pageof 5